SCHEMBL6205331

SCHEMBL6205331

Brc1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350 1.00 — —
SCHEMBL29520025 1.00 — —
SCHEMBL28445086 0.97 — —
Hydrochloric Acid SCHEMBL2815704 0.97 — —
SCHEMBL2997300 0.97 — —
SCHEMBL31574212 0.97 — —
Bromide SCHEMBL2221070 0.97 — —
Ammonia Solution, Strong SCHEMBL509987 0.97 — —
SCHEMBL22462301 0.97 — —
SCHEMBL31300427 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 — — EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 — — WO disclosed
Send feedback